• Safi Bello

WHO Plans to Bring Cheap Biosimilar Cancer Drugs to Poor

Scientific American ------- The World Health Organization (WHO) is to launch a pilot project this year to assess cheap copies of expensive biotech cancer drugs in a bid to make such medicines more widely available in poorer countries. The U.N. agency said on Thursday it would invite drugmakers in September to submit applications for prequalification of so-called biosimilar versions of two such drugs on its essential medicines list, Roche's Rituxan and Herceptin. WHO also plans to explore options for prequalifying biosimilar insulin. The move is a boost for biosimilars which are expected to account for a growing proportion of treatments, particularly for cancer, as patents on the original branded products expire. To learn more click on the picture below to read the article.

WHO Plans to Bring Cheap Biosimilar Cancer Drugs to Poor - Read More from Scientific American

4 views
Featured Posts
Recent Posts
Follow Us
  • Instagram
  • Pinterest
  • Tumblr Social Icon